全文获取类型
收费全文 | 140922篇 |
免费 | 8209篇 |
国内免费 | 1192篇 |
专业分类
耳鼻咽喉 | 2246篇 |
儿科学 | 2125篇 |
妇产科学 | 2086篇 |
基础医学 | 22374篇 |
口腔科学 | 3621篇 |
临床医学 | 13218篇 |
内科学 | 25191篇 |
皮肤病学 | 4472篇 |
神经病学 | 11405篇 |
特种医学 | 7982篇 |
外科学 | 18488篇 |
综合类 | 645篇 |
现状与发展 | 3篇 |
一般理论 | 34篇 |
预防医学 | 7350篇 |
眼科学 | 3505篇 |
药学 | 12705篇 |
中国医学 | 1628篇 |
肿瘤学 | 11245篇 |
出版年
2023年 | 995篇 |
2022年 | 3027篇 |
2021年 | 4864篇 |
2020年 | 2375篇 |
2019年 | 3331篇 |
2018年 | 4124篇 |
2017年 | 3356篇 |
2016年 | 4417篇 |
2015年 | 6032篇 |
2014年 | 7091篇 |
2013年 | 8340篇 |
2012年 | 12389篇 |
2011年 | 11874篇 |
2010年 | 6846篇 |
2009年 | 5861篇 |
2008年 | 8320篇 |
2007年 | 7822篇 |
2006年 | 7021篇 |
2005年 | 6571篇 |
2004年 | 5689篇 |
2003年 | 4979篇 |
2002年 | 4310篇 |
2001年 | 3295篇 |
2000年 | 3031篇 |
1999年 | 2360篇 |
1998年 | 1008篇 |
1997年 | 762篇 |
1996年 | 574篇 |
1995年 | 505篇 |
1994年 | 455篇 |
1993年 | 394篇 |
1992年 | 850篇 |
1991年 | 813篇 |
1990年 | 740篇 |
1989年 | 652篇 |
1988年 | 550篇 |
1987年 | 540篇 |
1986年 | 412篇 |
1985年 | 428篇 |
1984年 | 303篇 |
1983年 | 228篇 |
1982年 | 160篇 |
1981年 | 193篇 |
1980年 | 153篇 |
1979年 | 276篇 |
1978年 | 199篇 |
1976年 | 152篇 |
1975年 | 172篇 |
1974年 | 169篇 |
1972年 | 146篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
Seunghan Ha Minhee Lee Onseok Lee Gunwoo Lee Jeayoung Kim Jongsub Moon Mingi Kim Chilhwan Oh 《Skin research and technology》2009,15(2):200-213
Background/aims: The objective and quantitative assessment of the skin is important in medical and cosmeceutical research. Assessment of color is an important element for analyzing the surface of the skin, which is usually determined subjectively by a doctor or using color analysis devices. These devices, however, cannot provide correct color information because color is construed from the mean value of the observation region, and analysis of color distribution is impossible. The purpose of this paper is to develop an objective analysis method to permit skin color measurement of each pixel unit of an image and analyze the distribution of skin surface color. Methods: The Skin Color Distribution Analyzer (SCDA) is an analysis method newly developed at the Research Institute for Skin Image at Korea University. The SCDA system presented in this paper performed a novel form of quantitative and objective analysis of skin color distribution using each pixel color model parameter found in image wavelength information. In this paper, distribution analysis was conducted on normal skin and skin lesions and skin affected by artificially induced irritant contact dermatitis and pigmented nevous. The method selected a grade using a color model parameter. Twenty healthy Korean males participated in this study. A comparative study of the eight anatomical areas was performed, including the exposure and non‐exposure parts and the medial aspect and the lateral aspect of the forearm. A reliability test for the SCDA system was also conducted with a spectrometer (SPEC) using the color analysis method. Results: Each skin lesion was precisely segmented by grade and each parameter hada different statistical significance for results of analysis of distribution in pigmented nevous and the artificially induced irritant contact dermatitis. Parameters L*, b*, a*, and EI showed salient traits. Showed resemble measured result in the SCDA system and the SPEC of normal skin. The exposed site, in comparison with the non‐exposed site, showed a notable difference in the L* parameter and a significant statistical difference in the x and z parameters, except b*. The comparison of the medial and lateral aspects of the forearm showed a notable difference in the L* parameter and a significant statistical difference in the parameters except y and b*. In the reliability test result using the SCDA system and the SPEC, the SCDA system was highly reliabile in terms of the CV value in all color model parameters. Conclusions: The color distribution analysis method using the SCDA system has revealed an aspect that the existent method of medical research has not shown, and is considered to be more reliable than other methods. This method can provide better study findings because it can be applied to other fields in addition to the medical science field and the ripple effect is thought to be bigger in other science field too. 相似文献
23.
24.
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. 总被引:1,自引:0,他引:1
Beta-adrenergic receptor density on T cells from healthy humans is greatest on suppressor cells (CD8+, CD28-) and the effect of catecholamines, secreted by the sympathetic nervous system, predominates on this subset. The sympathetic skin response, a measure of sympathetic nervous system function, is absent in most patients with chronic progressive multiple sclerosis (MS). We measured beta-adrenergic receptor density on suppressor cells, cytotoxic cells, and monocytes from patients with chronic progressive MS and healthy control subjects. Control receptor density on suppressor cells was 2.8 +/- 0.3 fmol/10(6) cells versus a density of 5.1 +/- 0.7 fmol/10(6) cells for patients. Cytotoxic cell (CD8+, CD28+) receptor density was 1.4 +/- 0.4 fmol/10(6) cells in control subjects and 0.9 +/- 0.3 fmol/10(6) cells in the patients. Monocytes displayed beta-adrenergic receptor densities of 2.6 +/- 0.4 fmol/10(6) cells in normal individuals and 2.7 +/- 0.4 fmol/10(6) cells in the patient group. CD8 lymphocyte beta-adrenergic receptor densities in patients with relapsing-remitting and those with stable MS were not different from control values, yet were significantly less than the values for patients with chronic progressive MS. We find that mononuclear cells from healthy control subjects and patients with chronic progressive MS proliferate in response to 200 units/ml of recombinant human interleukin-2 (IL-2) similarly. However, IL-2 treatment increased beta-adrenergic receptor density on normal mononuclear cells, but failed to increase it on mononuclear cells from patients with chronic progressive MS.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
25.
26.
27.
28.
29.
30.
Diseases like rotavirus afflict both upper- and lower-income countries, but most serious illnesses and deaths occur among the latter. It is a vital public health issue that vaccines for these types of global diseases can recover research and development (R&D) costs from high-priced markets quickly so that manufacturers can offer affordable prices to lower-income nations. Cost recovery depends on how high R&D costs are, and this study attempts to replace high, unverified estimates with lower, more verifiable estimates for two new vaccines, RotaTeq (Merck) and Rotarix (GlaxoSmithKline or GSK), based on detailed searches of public information and follow-up interviews with senior informants. We also offer a new perspective on “cost of capital” as a claim for recovery from public bodies. Our estimates suggest that companies can recover all fixed costs quickly from affluent markets and thus can offer these vaccines to lower-income countries at prices they can afford. Better vaccines are a shared project between companies and public health agencies; greater transparency and consistency in reporting of R&D costs is needed so that fair prices can be established. 相似文献